Track topics on Twitter Track topics that are important to you
Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen’s discovery efforts are based on a decade long focus on in silico (by computer) prediction and selection of therapeutic and diagnostic product candidates utilizing a growing number of field focused proprietary discovery platforms accurately modeling biological processes at the molecular level. Compugen’s growing number of collaborations with major pharmaceutical and diagnostic companies cover both (i) the licensing of product candidates discovered by Compugen during the validation of its discovery platforms and in its internal research, and (ii) “discovery on demand” agreements where existing or new Compugen discovery platforms are utilized to predict and select product candidates as required by our partner. In 2002, Compugen established an affiliate, Evogene Ltd. (TASE: EVGN.TA) to utilize certain of the Company’s in silico predictive discovery capabilities in agricultural biotechnology. Compugen has been publicly traded on Nasdaq (NASDAQ: CGEN) since August 2000 and on the Tel Aviv Stock Exchange since January 2002.
72 Pinchas Rosen St.
Compugen to manufacture COM902 for clinical trials
Tel Aviv, Israel-based Compugen has updated its collaborative activities in immuno-oncology with Germany’s…
Do we really have a good understanding of how life works at a molecular level? Martin Gerstel, Chairman of Compugen, explains how the company has created a computer that can accurately model the behav...
In this interview, filmed at BIO Europe 2013 in Vienna, Paul Larsmon speaks to Tsipi Keren-Lehrer, Vice President, Business Development at Compugen. They discuss how Compugen model key biological phe...
Life Sciences Jobs ...
Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are b...
Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen’s discovery efforts are based...
Compugen is a leading therapeutic product discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology ...
Neviah Genomics was jointly established in 2012 by Merck Serono, the biopharmaceutical business of Merck, and Compugen Ltd. The company operates out of the MS Venturesâ Israe...
BioLineRx Ltd. is a publicly-traded biopharmaceutical development company. It is dedicated to building a portfolio of products for unmet medical needs or with advantages over curr...
We have published hundreds of Compugen news stories on BioPortfolio along with dozens of Compugen Clinical Trials and PubMed Articles about Compugen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Compugen Companies in our database. You can also find out about relevant Compugen Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...